EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Alzheimer incidence and prevalence with and without asthma: A Medicare cohort study

Christie M Bartels, Yi Chen, W Ryan Powell, Melissa A Rosenkranz, Barbara B Bendlin, Joseph Kramer, William W Busse, Amy Kind

Journal of Allergy and Clinical Immunology · 2024

DOI: 10.1016/j.jaci.2024.04.008 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Christie M Bartels und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis; Center for Health Disparit…. Hauptthemen laut MEDLINE: Asthma, Alzheimer Disease, Medicare. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: International data suggest that asthma, like other inflammatory diseases, might increase Alzheimer disease (AD) risk. OBJECTIVE: We sought to explore risk pathways and future mitigation strategies by comparing diagnostic claims-based AD incidence and prevalence among US patients with asthma with those without asthma. METHODS: This cohort study included a national Medicare 20% random sample (2013-2015). Adult patients with asthma with more than 12 months continuous Medicare were compared with subjects without asthma overall and as matched. Asthma was defined by 1 inpatient or 2 outpatient codes for asthma. The main outcomes were 2-year incident or prevalent AD defined by International Classification of Diseases, Ninth Revision code 331.0 or Tenth Revision code G30.0, G30.1, G30.8, or G30.9. RESULTS: Among 5,460,732 total beneficiaries, 678,730 patients were identified with baseline asthma and more often identified as Black or Hispanic, were Medicaid eligible, or resided in a highly disadvantaged neighborhood than those without asthma. Two-year incidence of AD was 1.4% with asthma versus 1.1% without asthma; prevalence was 7.8% versus 5.4% (both P ≤ .001). Per 100,000 patients over 2 years, 303 more incident AD diagnoses occurred in those with asthma, with 2,425 more prevalent cases (P < .001). Multivariable models showed that asthma had greater odds of 2-year AD incidence (adjusted odds ratio, 1.33 [95% CI, 1.29-1.36]; matched 1.2 [95% CI, 1.17-1.24]) and prevalence (adjusted odds ratio, 1.48 [95% CI, 1.47-1.50]; matched 1.25 [95% CI, 1.22-1.27]). CONCLUSIONS: Asthma was associated with 20% to 33% increased 2-year incidence and 25% to 48% increased prevalence of claims-based AD in this nationally representative US sample. Future research should investigate risk pathways of underlying comorbidities and social determinants as well as whether there are potential asthma treatments that may preserve brain health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAlzheimer DiseaseMedicareHumansUnited StatesMaleFemaleIncidenceAgedPrevalenceCohort StudiesAged, 80 and overMiddle AgedRisk Factors

Stichwörter der Autor:innen

AlzheimerAsthmaclaims-based datacohort studyobservational studysystemic inflammation

Autor:innen und Institutionen

  • Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis; Center for Health Disparities Research, University of Wisconsin School of Medicine and Public He…
  • Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
  • Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison, Wis; Geriatrics Division, Department of Medicine, University of Wisconsin School of Medicine and Public Heal…
  • Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, Wis; Center for Healthy Minds, University of Wisconsin-Madison, University of Wisconsin School of Medicine and Public Heal…
  • Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
  • Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS
  • NIMHD NIH HHS
  • NIH

Zitieren

APA

Bartels, C. M., Chen, Y., Powell, W. R., Rosenkranz, M. A., Bendlin, B. B., Kramer, J., Busse, W. W., & Kind, A. (2024). Alzheimer incidence and prevalence with and without asthma: A Medicare cohort study. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.04.008

Vancouver

Bartels CM, Chen Y, Powell WR, Rosenkranz MA, Bendlin BB, Kramer J, et al. Alzheimer incidence and prevalence with and without asthma: A Medicare cohort study. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2024.04.008

BibTeX
@article{Bartels2024,
  author = {Bartels, Christie M and Chen, Yi and Powell, W Ryan and Rosenkranz, Melissa A and Bendlin, Barbara B and Kramer, Joseph and Busse, William W and Kind, Amy},
  title = {Alzheimer incidence and prevalence with and without asthma: A Medicare cohort study},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.jaci.2024.04.008}
}
Kostenlos starten →